Average Co-Inventor Count = 7.70
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (17 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
20 patents:
1. 9469615 - [object Object]
2. 8598158 - Fused tricyclic compounds for the treatment of inflammatory disorders
3. 8283360 - Bicyclic heterocyclic derivatives and methods of use thereof
4. 7956189 - Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methoxy-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore
5. 7763623 - Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
6. 7750015 - Nitrogen-containing heterocyclic compounds and methods of use thereof
7. 7737155 - Nitrogen-containing heterocyclic compounds and methods of use thereof
8. 7723342 - Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
9. 7511062 - Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
10. 7354922 - [object Object]
11. 6635630 - Selective neurokinin antagonists
12. 6436928 - Selective neurokinin antagonists
13. 6051575 - Piperazino derivatives as neurokinin antagonists
14. 5981520 - Piperazino derivatives as neurokinin antagonists
15. 5968929 - Piperazino derivatives as neurokinin antagonists